Phase 2 study of letrozole, abemaciclib, and metformin in estrogen receptor (ER)–positive recurrent endometrial cancer (EC). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
JEE Mains 2026 registration starts soon. Know tentative chapter-wise weightage from past years to strategize your preparation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback